Best Performing Stocks To Buy Right Now

Citigroup’s Wendy Nicholson and Beth Kite argue that the once “untouchable” Avon Products (AVP) “has become intriguing.” They explain why:

Getty Images

After Avon was the worst performing stock in the HPC group in 2015 (down nearly 60%), Avon has been the best performing stock in our coverage universe year-to-date in 2016 (up ~65%). While we have no explanation specifically for the recent strength in the stock (and especially heavy trading volume), we think there are several factors that help explain why the stock has out-performed the market so handily so far this year, above and beyond the fact that the stock entered the year at an awfully depressed price. Specifically, Avon now seems to be more of an investable name than it had been previously, owing to (i) refinancing of debt has allayed bankruptcy concerns, (ii) investment by Cerberus has boosted confidence in managements execution-ability, (iii) the sale of the U.S. business has eliminated a previous drag to profits, (iv) the relative stabilization of U.S. dollar has tempered f/x headwinds, and (v) AVPs organic sales growth trends improved to ~+4% YoY in 1H16.

Best Performing Stocks To Buy Right Now: Exactech Inc.(EXAC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Best Performing Stocks To Buy Right Now: Aurinia Pharmaceuticals Inc(AUPH)

Advisors’ Opinion:

  • [By Keith Speights]

    That statement comes to mind when I think about Aurinia Pharmaceuticals (NASDAQ:AUPH). The potential for the clinical-stage biotech appears to be so great that getting greedy with the stock is tempting.

  • [By Lisa Levin] Related NVCN 18 Biggest Mid-Day Losers For Wednesday Legal Overhangs Keep Ladenburg Neutral On Neovasc Despite Positive Tiara Clinical Data Boston Scientific closes Neovasc transaction (Seeking Alpha)
    Related BSX Watch These 10 Huge Call Purchases In Monday Trade Wonderful Wearables Get Their Own ETF Boston Scientific closes Neovasc transaction (Seeking Alpha) Gainers
    Neovasc Inc (US) (NASDAQ: NVCN) rose 17.3 percent to $2.65 in pre-market trading after the company reported the close of its $75 million transaction with Boston Scientific Corporation (NYSE: BSX).
    aTyr Pharma Inc (NASDAQ: LIFE) shares rose 12.3 percent to $4.10 in pre-market trading after the company disclosed 'promising' signals in myopathies with Resolaris in exploratory trials.
    Globus Maritime Ltd (NASDAQ: GLBS) shares rose 10.1 percent to $6.90 in pre-market trading after climbing 5.03 percent on Monday.
    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares rose 9.9 percent to $3.00 in pre-market trading. Aurinia Pharmaceuticals appointed Lorin Jeffry “Jeff” Randall to its board and Chairman of the Audit Committee.
    Ocean Rig UDW Inc. (NASDAQ: ORIG) shares rose 8.7 percent to $2.89 in pre-market trading after surging 19.82 percent on Monday.
    Full House Resorts, Inc. (NASDAQ: FLL) shares rose 5.1 percent to $2.08 in pre-market trading after declining 1.98 percent on Monday.
    Seadrill Ltd (NYSE: SDRL) rose 5.1 percent to $4.13 in pre-market trading after surging 3.15 percent on Monday.
    Noble Corporation (NYSE: NE) rose 5.1 percent to $7.60 in pre-market trading after declining 5.37 percent on Monday.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 5.1 percent to $3.10 in pre-market trading. Arbutus issued additional data from its ARB-1467 Phase II
  • [By Todd Campbell]

    After positive mid-stage trial data suggested earlier this year that it might be able to reshape the treatment of kidney failure in lupus patients, Aurinia Pharmaceuticals (NASDAQ:AUPH)has announced plans for a late-stage study that could eventually allow it to win regulatory OKs in the U.S., Europe, and Japan.

Best Performing Stocks To Buy Right Now: International Tower Hill Mines Ltd(THM)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Best Performing Stocks To Buy Right Now: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Energous Corporation and potential small cap networking or power peer Acacia Communications (NASDAQ: ACIA) having a run up late last year while small cap Ultralife Corp (NASDAQ: ULBI) is heading back up to previous highs and EnSync Inc (NYSEMKT: ESNC) has underperformed:

Best Performing Stocks To Buy Right Now: Skechers U.S.A., Inc.(SKX)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Shares of Skechers(NYSE:SKX)are sliding on Friday after posting poorly received first-quarter results. The walking and casual athletic-footwear specialist posted record net sales of $1.25 billion, but between decelerating revenue growth during the seasonally potent quarter, failing to blow past its guidance the way it did last time out, and offering up uninspiring guidance it just wasn’t enough for the stock to justify the multiyear high it hit earlier in the week.

  • [By Demitrios Kalogeropoulos]

    Below we’ll look at three companies –Amazon.com (NASDAQ:AMZN), Logitech (NASDAQ:LOGI), and Skechers USA (NYSE:SKX)– that grew by at least 400% over that period.

  • [By Matt Hogan]

    Skechers USA Inc (NYSE: SKX) is expected to report earnings on Thursday after the market closes. The footwear company has generally traded lower over the last eight quarters in the face of decelerating revenue growth. The stock had been gaining some momentum in the early part of the year until Susquehanna's Sam Poser downgraded the company to a negative rating on March 29th. Poser warned that domestic wholesale growth would fall short of investor expectations and the stock has since fallen 15 percent.